EC Number   |
Title |
Organism |
|---|
   3.4.22.34 | Biological function of Dictyocaulus viviparus asparaginyl peptidase legumain-1 and its suitability as a vaccine target |
Dictyocaulus viviparus |
| 3.4.22.34 | Characterization of the legumains encoded by the genome of Theobroma cacao L |
Theobroma cacao |
| 3.4.22.34 | Crystal structure of plant legumain reveals a unique two-chain state with pH-dependent activity regulation |
Arabidopsis thaliana |
| 3.4.22.34 | Development of a potent and selective cell penetrant Legumain inhibitor |
Homo sapiens |
| 3.4.22.34 | Distinct roles of catalytic cysteine and histidine in the protease and ligase mechanisms of human legumain as revealed by DFT-based QM/MM simulations |
Homo sapiens |
| 3.4.22.34 | Expression and protease activity of mouse legumain are regulated by the oncogene/transcription co-activator, DJ-1 through p53 and cleavage of annexin A2 is increased in DJ-1-knockout cells |
Mus musculus |
| 3.4.22.34 | Flat SAR of P3-methylsulphonamide based small molecule legumain inhibitors |
Homo sapiens |
| 3.4.22.34 | Functional recombinant human Legumain protein expression in Pichia pastoris to enable screening for Legumain small molecule inhibitors |
Homo sapiens |
| 3.4.22.34 | Glycosylation is important for legumain localization and processing to active forms but not for cystatin E/M inhibitory functions |
Bos taurus |
| 3.4.22.34 | Identification and SAR exploration of a novel series of legumain inhibitors |
Homo sapiens |
